Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2021 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial.
Asherie N, Kfir-Erenfeld S, Avni B, Assayag M, Dubnikov T, Zalcman N, Lebel E, Zimran E, Shaulov A, Pick M, Cohen Y, Avivi I, Cohen C, Gatt ME, Grisariu S, Stepensky P. Asherie N, et al. Among authors: zalcman n. Haematologica. 2023 Jul 1;108(7):1827-1839. doi: 10.3324/haematol.2022.281628. Haematologica. 2023. PMID: 36200421 Free PMC article. Clinical Trial.
Androgen receptor: a potential therapeutic target for glioblastoma.
Zalcman N, Canello T, Ovadia H, Charbit H, Zelikovitch B, Mordechai A, Fellig Y, Rabani S, Shahar T, Lossos A, Lavon I. Zalcman N, et al. Oncotarget. 2018 Apr 13;9(28):19980-19993. doi: 10.18632/oncotarget.25007. eCollection 2018 Apr 13. Oncotarget. 2018. PMID: 29731997 Free PMC article.
[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.
Orevi M, Shamni O, Zalcman N, Chicheportiche A, Mordechai A, Moscovici S, Shoshan Y, Shahar T, Charbit H, Gutreiman M, Paldor I, Mishani E, Lossos A, Lavon I. Orevi M, et al. Among authors: zalcman n. Neurooncol Adv. 2021 Jan 29;3(1):vdab019. doi: 10.1093/noajnl/vdab019. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 33738450 Free PMC article.